Ultrasound-guided filler dissolution: what can it clarify?

Ultrasound may help assess location and plan targeted intervention in selected filler problems.

Illustrative medical image; does not depict an actual patient, treatment outcome or individual treatment plan.

On this page

Which questions can ultrasound help answer?

First clarify symptom onset, previous injections and current findings. Ultrasound can add information in selected cases; not every swelling or irregularity can be attributed solely to remaining filler. U1 F1

Situation	Assessment aim	Possible tool	Decision question	Limitation
Location question	Assess where material lies	Ultrasound and examination	Is a targeted approach appropriate?	Operator and interpretation matter U1
HA-related irregularity	Relate material to symptoms	History and examination	Might hyaluronidase be considered?	Small experimental study does not represent complex under-eye cases U2
Unknown or permanent filler	Clarify product and problem	Records and further assessment	Is another approach needed?	Not every filler can be dissolved F1

The targeted-ultrasound study examined selected vascular complications. Its findings should not be generalized into superiority, low risk or certain success for every elective correction. U1 U2

Which options may be considered?

Depending on examination, options may include observation, consideration of hyaluronidase for HA filler or treatment of another problem. Studies concern specific materials and settings; this guide provides no dose or injection plan. U1 U2

Imaging does not remove all uncertainty. Findings must fit examination and product history; one session, complete removal or return to the previous appearance cannot be guaranteed. U1

How should you prepare for consultation?

Bring product details if available, treatment dates, sites, previous dissolution and a symptom timeline. Report allergies, medicines and new redness or fever. If records are missing, say so rather than guessing. F1 U3

Which risks need discussion?

Dissolution has risks, including local reactions and allergy. Suspected infection needs separate assessment. A US hyaluronidase label concerns one product; it does not establish Turkish authorization or the clinic’s stock. F1 U3

How is follow-up approached?

Follow-up depends on symptoms, examination and intervention. Persistent or worsening problems need reassessment; new filler is not an automatic next step. F1 C2

What are the common questions?

Can ultrasound identify every filler with certainty?

No. Imaging can help locate material; it is not a universal test that definitively identifies every product. U1

Does hyaluronidase dissolve every filler?

No. HA must be distinguished from other or permanent materials. Removal can be difficult or impossible, and other approaches also have risks. U2 F1

Is one session enough?

It cannot be promised in advance. Studies do not cover every site, product and complex case; goals and response need review. U1 U2

What if infection is suspected?

Report redness, tenderness or discharge. Medical assessment is needed rather than continuing routine dissolution planning before possible infection is clarified. F1 U3

Should visual change wait for ultrasound?

No. Sudden visual change needs emergency assessment. Ultrasound is not a prerequisite to place ahead of urgent care. U1 F1